Ausgabe 9/2004
Inhalt (5 Artikel)
Global Registries for Measuring Pharmacoeconomic and Quality-of-Life Outcomes
Lisa Kennedy, Ann-Marie Craig
Cost Effectiveness and Cost Utility of Adjuvant Interferon α in Cutaneous Melanoma
Ralph Crott
A Cost-Effectiveness Analysis of Docetaxel in the Second-Line Treatment of Non-Small Cell Lung Cancer
Jeremy Holmes, David Dunlop, Lindsay Hemmett, Peter Sharplin, Uday Bose
The Burden of Migraine in Spain
Xavier Badia, Sol Magaz, Laura Gutiérrez, Jordi Galván
A Cost-Effectiveness Analysis of Fondaparinux Sodium Compared with Enoxaparin Sodium as Prophylaxis Against Venous Thromboembolism
Sean D. Sullivan, Bruce L. Davidson, Susan R. Kahn, James E. Muntz, Gerry Oster, Gary Raskob